DCM

DAFNA Capital Management Portfolio holdings

AUM $405M
1-Year Est. Return 24.52%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+24.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$126M
AUM Growth
+$10.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
111
New
Increased
Reduced
Closed

Top Buys

1
+$2.83M
2
+$2.52M
3
+$2.08M
4
IMMU
Immunomedics Inc
IMMU
+$1.89M
5
SYRE icon
Spyre Therapeutics
SYRE
+$1.7M

Top Sells

1
+$2.49M
2
+$2.21M
3
+$1.89M
4
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
+$1.37M
5
CYAD
Celyad Oncology SA American Depositary Shares
CYAD
+$1.32M

Sector Composition

1 Healthcare 71.02%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$165K 0.13%
+29,167
77
$123K 0.1%
368
-4
78
$115K 0.09%
22,559
-119,066
79
$108K 0.09%
630
80
$69K 0.05%
3,750
81
$59K 0.05%
170
82
$55K 0.04%
9,580
83
$47K 0.04%
45,000
84
$14K 0.01%
2,499
-173,733
85
$10K 0.01%
476
86
$6K ﹤0.01%
23
-214
87
$5K ﹤0.01%
53,488
-202
88
– –
0
89
– –
-4,670
90
– –
-149,642
91
– –
-136,047
92
– –
-75
93
– –
-5,631
94
– –
-432
95
– –
-125,000
96
– –
-3,459
97
– –
-74,350
98
– –
-30,000
99
– –
-10
100
– –
-250
1 2 3
4
5